MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 2931-2940 Newer>
Managed Care
May 2006
Martin Sipkoff
Part D Means Health Plans Will Have To Pay Pharmacists Medication therapy management helps people to stay on their prescribed regimens. Part D plans can expect to start making payments for the service in 2007. mark for My Articles 112 similar articles
Managed Care
May 2006
Patients Want Better Quality so Long as They Don't Have to Pay for it While about half of adults believe that there are fair and reliable ways to assess health care quality, only 19 percent think it would be justifiable for patients to pay more when treated by medical groups or hospitals that provide better care. mark for My Articles 88 similar articles
Managed Care
May 2006
Physician Disclosure Strengthens Patients' Trust Patients who received a disclosure felt more competent to judge the effect of their physician's compensation on their health care, and nearly a quarter of patients who remembered receiving a disclosure reported that it had increased their trust in their primary care physician. mark for My Articles 491 similar articles
Managed Care
May 2006
Michael S. Victoroff
P4P Programs Offer Catnip That May Distract Doctors Current pay-for-performance programs apply only to a handful of diseases. If we don't pay for all the other diseases, will they get short shrift? mark for My Articles 162 similar articles
Managed Care
May 2006
Thomas Morrow
Cost Effective Psoriasis Treatment May Demand Creative Coverage Rules While biologic agents can be costly, a new formulation of an old treatment can mean inexpensive and effective relief. mark for My Articles 70 similar articles
The Motley Fool
May 31, 2006
Stephen D. Simpson
Vical Gets a Helping Hand Japan's AnGes MG's Allovectin-7 vaccine is now a risk-free lottery ticket for Vical. If phase 3 trials show adequate efficacy, there's upside. If the trials fail, Vical really doesn't lose much of anything. Investors, take note. mark for My Articles 192 similar articles
The Motley Fool
May 31, 2006
Brian Gorman
Novartis Gets Its Way FDA approval for Omnitrope suggests Novartis has a bright future in biogenerics, and that's good news for the company's investors. mark for My Articles 118 similar articles
The Motley Fool
May 31, 2006
Stephen D. Simpson
Healthways Pays to Jump Ahead The health-care management program provider announced an acquisition of private competitor LifeMasters Supported SelfCare. This deal may not be strictly necessary, but it could accelerate the company's existing plans. Investors, take note. mark for My Articles 17 similar articles
The Motley Fool
May 30, 2006
Rich Duprey
NICE Not Playing Nice With Alzheimer's The British health authority proposes limiting availability of Alzheimer's treatments because of cost. What will this mean to drug-makers and their shareholders? mark for My Articles 644 similar articles
HBS Working Knowledge
May 29, 2006
A Business Plan to Fight Disease Avichai Kremer devised a three-pronged plan centered on reaching out to researchers in Israel, raising funds, and building public awareness of the ALS and its lack of a cure. mark for My Articles 18 similar articles
<Older 2931-2940 Newer>    Return to current articles.